Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation
AssigneeVanderbilt University
InventorsJack J. Hawiger, Ruth Ann Veach, Yan Liu, Huan Qiao, Lukasz S. Wylezinski
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods for preventing and reducing inflammation and preventing and treating diseases and disorders associated with inflammation. It has been shown that CRADD plays a pivotal role in maintaining the integrity of endothelial monolayers. The recombinant cell-penetrating CRADD protein (CP-CRADD)-based compositions and methods described herein provide for the development of a novel treatment for inflammatory vascular disorders including cardiovascular, cerebrovascular, respiratory, gastrointestinal, and renal systems.
Claims6
A method of treating BCL10-mediated inflammation in a mammalian subject comprising administering to the mammalian subject a composition comprising a pharmaceutically acceptable carrier and a cell-penetrating full-length caspase and receptor interacting protein adaptor with death domain (CP-CRADD), CP-CRADD that lacks its death domain or CP-CRADD that lacks its caspase recruitment domain (CARD) and further comprising, a membrane-translocating motif (MTM) having the sequence AAVLLPVLLAAP (SEQ ID NO:
- 1), AAVALLPAVLLALLAP (SEQ ID NO:2), or VTVLALGALAGVGVG (SEQ ID NO:3), in an amount sufficient to reduce or block B-cell lymphoma 10 (BCL10) expression or activity thereby reducing or blocking BCL10-mediated inflammation and/or treating a condition associated with BCL10-mediated inflammation in the mammalian subject.
Dependencies are inferred from the claim text.